Inflammatory Bowel Disease News

Doctor Accused of 'Fraudulent Concealment' Can't Be Held Liable Claim against hospital is halted as well.
Medscape Business of Medicine, May 18, 2022
A GI Doc's Help Can Be Crucial for Pregnant Women With IBD Women with inflammatory bowel disease (IBD) face several concerns related to their reproductive health decisions, from contraception to pregnancy to delivery.
WebMD Health News, May 16, 2022
DDW 2022 IBD After Age 60: More Evidence Antibiotics Play a Role Antibiotic type, frequency, and timing were assessed in a study of the development of inflammatory bowel disease later in life.
Medscape Medical News, May 16, 2022
Steroids Less Effective in Older-Onset Ulcerative Colitis Clinical remission rates at 30 days were lower among patients with older-onset UC compared to younger-onset cases.
Medscape Medical News, May 10, 2022
Periodontitis May Be Linked With Systemic Diseases Periodontitis may be associated with Alzheimer's disease and other chronic disorders, according to epidemiologic studies. The data suggest the importance of oral health for overall health.
Medscape Medical News, May 09, 2022
Understanding Toxin Testing Results for C diff Testing stool samples for C difficile exotoxins A and B is frequently used to diagnose a C difficile infection, but clinicians need a greater understanding of what the results mean.
Medscape Medical News, May 06, 2022
BSR 2022 IBD Risk 'Uncertain' in Biologic-Treated Patients With AxSpA 'Enormous uncertainty' surrounds the risk of inflammatory bowel disease associated with biologic treatment in patients with axial spondyloarthritis.
Medscape Medical News, April 28, 2022
How SDOH Impact Disparities in IBD Care, Outcomes Focusing on social determinants of health as the root cause of health inequity in IBD is essential to improve outcomes for marginalized patients, say the authors of a new paper.
Medscape Medical News, April 28, 2022
TNF Blockers Beat Newer Biologics in Crohn's Disease TNF blockers may work better than newer biologics for treating moderate to severe Crohn's disease.
Medscape Medical News, April 28, 2022
Schizophrenia Raises Risk of Inflammatory Bowel Disease In support of gut-brain interactions, a large study finds a greater than threefold increased risk of new-onset IBD in patients with schizophrenia.
Medscape Medical News, April 28, 2022
Two-Year Data for Ixekizumab in Pediatric Psoriasis Reported More than half of patients had achieved 100% clearance with the IL-17 inhibitor at 2 years.
Medscape Medical News, April 25, 2022
TNF Inhibitors Prior to Surgery Safe in Patients With IBD: Study The rate of postoperative infection is no different between patients exposed to and those unexposed to tumor necrosis factor inhibitors in the 12 weeks before surgery.
Medscape Medical News, April 19, 2022
Adding Thiopurines to Vedolizumab Has Benefits in Crohn's Disease For patients with Crohn's disease, combining thiopurines with vedolizumab may be more effective than vedolizumab alone, new findings suggest.
Reuters Health Information, April 15, 2022
Psychiatric Illness Associated With Eosinophilic Esophagitis Among patients with eosinophilic esophagitis, there is a high prevalence of psychiatric illnesses, according to a new study.
Medscape Medical News, April 18, 2022
IBD: Patients Struggle With Mental Health, Work Presenteeism Anxiety and depression are common among individuals with IBD who are in remission, and the conditions are linked to unemployment and presenteeism, according to a prospective study.
Medscape Medical News, April 05, 2022
New Guidelines Tackle Antithrombotic Concerns in GI Procedures The common clinical concerns as to when to continue, hold, and resume antithrombotic agents during acute GI bleeds and elective endoscopy have been allayed by new evidence-based guidelines.
Medscape Medical News, March 29, 2022
Pfizer's Bowel Disease Drug Succeeds in Late-Stage Study Pfizer said on Wednesday its experimental treatment for an inflammatory bowel disease, acquired last year as part of its $6.7 billion deal for Arena Pharmaceuticals, succeeded in a late-stage trial.
Reuters Health Information, March 23, 2022
What's the Future of Microbiome Therapies in CDI, Cancer? Preventive treatments for C difficile recurrence are in phase 3 trials. Oncologists are also investigating microbiome-based differences in treatment response.
Medscape Medical News, March 18, 2022
Higher Adalimumab Dosing Regimens May Have Benefit in Ulcerative Colitis A higher-than-standard maintenance (but not induction) dosing regimen of adalimumab may be beneficial for some patients with moderate to severe ulcerative colitis, according to results of the SERENE UC study.
Reuters Health Information, March 10, 2022
ECCO 2022 AI Aids in Assessment of Ulcerative Colitis Activity, Remission Artificial intelligence systems have the potential to supplement the services of expert histopathologists and endoscopists rather than replace them.
Medscape Medical News, March 04, 2022

No Results